The first reported robotic double transplant of a liver and kidney was performed by WashU Medicine surgeons operating in the ...

WashU Medicine researchers reduced Alzheimer’s-like neurodegeneration in mice by preventing immune cells from traveling to ...

Study identifies brain differences tied to sensory distress, often linked to anxiety and autism.

Around 25% of people with cancer in the U.S. are active smokers when they are diagnosed, and studies have found that many of them continue to smoke during treatment. This may be due in part to a ...

New research links outdoor air pollution — even at levels deemed safe — to an increased risk of diabetes globally, according to a study from Washington University School of Medicine in St. Louis and ...

An aggressive type of brain cancer, glioblastoma has no cure. Patients survive an average of 15 months after diagnosis, with fewer than 10% of patients surviving longer than five years. While ...

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

Leaders across WashU Medicine foster a culture of ambition and achievement that improves the health of the region, the nation and the world. Some of these contributions leave such an indelible mark — ...

The first participants in an international clinical trial aimed at preventing Alzheimer’s disease in young adults at high risk of the disease have been enrolled. The trial, led by Washington ...

Researchers at Washington University School of Medicine in St. Louis have developed an approach to estimating when a person who is likely to develop Alzheimer’s disease, but has no cognitive symptoms, ...

Most cancer genome studies have focused on mutations in the tumor itself and how such gene variants allow a tumor to grow unchecked. A new study, led by researchers at Washington University School of ...